Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
EPA CPDat observed this chemical in 1000 composition records across product categories including Construction and building materials, Specialty occupational products, Home maintenance.
Concern score
The concern value reflects this ingredient's chemical identity — its hazard profile from the published classifications and regulatory status below — not the safety of a product it appears in. A score near 40 is the baseline for ingredients with no specific signal (water scores 40 by design), so a mid-range value is not a safety verdict.
Concern score 5/100 (low) · high confidence.
Prevalence of HYPROMELLOSE 2910 (5 MPA.S) in our catalog (epa_cpdat).
Products
1,000
Brands
6
Typical roles
Catalog
Context-specific fit derived from published classifications and the current ingredient evidence profile.
Food use
Food-use source coverage is present in the current record.
The ingredient appears in food-oriented source coverage or allowed-use references, which makes food use easier to support than a context with no domain signal at all.
Fragrance avoidance
No fragrance-linked caution surfaced in the current profile.
Primary documents currently linked to this ingredient record.
Structured claim signals pulled from linked ingredient research.
Published jurisdiction-level classifications and regulatory designations for this ingredient.
US
EPA
EPA CPDat observed this chemical in 1000 composition records across product categories including Construction and building materials, Specialty occupational products, Home maintenance. EPA CPDat classifies this chemical for functional uses including Viscosity modifier, Binder, Surfactant (surface active agent).
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Potency: 0.5 %w/v
US
FDA
Crème de douche Extra Douce Lait de Vanille Bio
Le Petit Marseillais
This ingredient does not currently read as a fragrance-linked driver in the published evidence and hazard profile.
The published evidence profile currently shaping this ingredient record.
Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.5 %w/w
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 3 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 1488 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 3.32 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 105 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Potency: 119.7 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 45 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Potency: 1.7 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 305 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 250 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1127 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: 11.8 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 58 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 79 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1472 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 582 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Potency: 221 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 41 mg
US
FDA
Route: RECTAL; Dosage form: GEL; Maximum daily exposure: 348 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Potency: 0.1 %w/w
US
FDA
Route: TOPICAL; Dosage form: SYSTEM; Maximum daily exposure: 54 mg
US
FDA
Route: VAGINAL; Dosage form: INSERT; Potency: 54.21 mg
US
FDA
Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 21 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 5 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 630 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 79 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 250 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 50 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 100 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 942 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 360 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 1700 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 360 mg
US
FDA
Route: VAGINAL; Dosage form: INSERT; Maximum daily exposure: 16 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 161 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 900 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1296 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 2147 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 1320 mg
US
FDA
Route: TOPICAL; Dosage form: LOTION; Maximum daily exposure: 7 mg
US
FDA
Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 17 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 222 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 375 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 4050 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 2640 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 19 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 40 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 24 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 15 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 428 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 38 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 470 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 325 mg
US
FDA
Route: SUBLINGUAL; Dosage form: TABLET; Maximum daily exposure: 5 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 78 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 40 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 88 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 300 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 256 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 960 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 40 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 96 mg
US
FDA
Route: TOPICAL; Dosage form: JELLY; Maximum daily exposure: 13800 mg
US
FDA
Route: VAGINAL; Dosage form: CREAM; Maximum daily exposure: 12 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 660 mg
US
FDA
Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 91 mg
US
FDA
Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Potency: 45.67 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 282 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, DELAYED RELEASE; Potency: 33.2 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 184 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Potency: 20 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 88 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 70 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 129 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 100 mg
US
FDA
Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 47 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 400 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 360 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 120 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 748 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 48 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 15 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 54 mg
US
FDA
Route: SUBLINGUAL; Dosage form: FILM; Maximum daily exposure: 7 mg
US
FDA
Route: VAGINAL; Dosage form: INSERT; Maximum daily exposure: 105 mg
US
FDA
Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 48 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 29 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Potency: 0.5 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 400 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 721 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 105 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 295 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 1 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 156 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 570 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 140 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 231 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 78 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 8 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 250 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 52 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 36 mg
US
FDA
Route: NASAL; Dosage form: SPRAY; Maximum daily exposure: 1 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Maximum daily exposure: 1 mg
US
FDA
Route: OPHTHALMIC; Dosage form: GEL; Maximum daily exposure: 1 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION; Maximum daily exposure: 2 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SOLUTION/ DROPS; Maximum daily exposure: 3 mg
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION; Potency: 0.5 %w/v
US
FDA
Route: OPHTHALMIC; Dosage form: SUSPENSION/ DROPS; Potency: 0.6 %w/v
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 190 mg
US
FDA
Route: ORAL; Dosage form: SOLUTION; Maximum daily exposure: 360 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 360 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION/ DROPS; Maximum daily exposure: 10 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 360 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 62 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 264 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Potency: 245 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Potency: 127.29 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 290 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 107 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 90 mg
US
FDA
Route: TOPICAL; Dosage form: JELLY; Maximum daily exposure: 1368 mg
US
FDA
Route: TOPICAL; Dosage form: SHAMPOO; Potency: 1.2 %w/w
US
FDA
Route: BUCCAL; Dosage form: GUM, CHEWING; Maximum daily exposure: 336 mg
US
FDA
Route: BUCCAL; Dosage form: TABLET; Maximum daily exposure: 5 mg
US
FDA
Route: NASAL; Dosage form: SPRAY, METERED; Potency: 1 mg/1ml
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 930 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 563 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 964 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 1447 mg
US
FDA
Route: ORAL; Dosage form: FILM, SOLUBLE; Maximum daily exposure: 201 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 48 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 2940 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 975 mg
US
FDA
Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 727 mg
US
FDA
Route: ORAL; Dosage form: SYRUP; Maximum daily exposure: 200 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1200 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 120 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 24 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 103 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 670 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 264 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 76 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 25 mg
US
FDA
Route: SUBLINGUAL; Dosage form: FILM; Potency: 4.68 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE; Maximum daily exposure: 600 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 156 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE PELLETS; Maximum daily exposure: 261 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 232 mg
US
FDA
Route: ORAL; Dosage form: CAPSULE, LIQUID FILLED; Maximum daily exposure: 31 mg
US
FDA
Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 5455 mg
US
FDA
Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 42 mg
US
FDA
Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 504 mg
US
FDA
Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 880 mg
US
FDA
Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 17 mg
US
FDA
Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 12 mg
US
FDA
Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 77 mg
US
FDA
Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 85 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 345 mg
US
FDA
Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 9 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 39 mg
US
FDA
Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 174 mg
US
FDA
FDA NDC lists this ingredient in 1 active drug products and 1 total products.
US
FDA
FDA NDC lists this ingredient in 3 active drug products and 5 total products.
US
FDA
FDA NDC lists this ingredient in 12 active drug products and 12 total products.
US
FDA
openFDA substance registry classifies this ingredient as polymer.